[1] |
XU Weiwei, HUANG Xianghua.
Immune microenvironment of monoclonal gammopathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2024, 33(1): 47-53.
|
[2] |
HONG Yi, GUO Jinzhou, CHEN Wencui, ZHAO Liang, HUANG Xianghua, LIU Zhihong.
Clinical characteristics and prognosis of multiple myeloma patients associated light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(5): 406-411.
|
[3] |
HU Ziyun, LIANG Dandan, ZENG Caihong.
Immunorelated pancytopenia concurrent with membranoproliferative glomerulonephritis with special microtubular deposits
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(3): 291-295.
|
[4] |
HONG Yi, ZHANG Yuanyuan, LI Zhen, HUANG Xianghua.
Advances in pathogenesis, diagnosis and treatment of systemic light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(2): 156-162.
|
[5] |
LIANG Dandan, CHEN Wencui, ZENG Caihong.
Nephronophthisis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(5): 490-493.
|
[6] |
XU Weiwei, REN Guisheng, GUO Jinzhou, ZHAO Liang, LIU Zhihong, HUANG Xianghua.
Pomalidomide and dexamethasone in treatment of systemic light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 304-309.
|
[7] |
XU Weiwei, GUO Jinzhou, REN Guisheng, et al.
A retrospective study of ixazomib and dexamethasone in patients with relapsed and refractory light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(6): 501-506.
|
[8] |
XU Feng, JIAO Chenfeng, XIE Honglang, et al.
Gemcitabine-associated thrombotic microangiopathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(6): 591-595.
|
[9] |
CHEN Wencui, REN Guisheng, LIANG Dandan, et al.
Heavy and light chain renal amyloidosois
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(6): 596-600.
|
[10] |
MIAO Fujia, REN Guisheng, GUO Jinzhou, ZHAO Liang, XU Weiwei, HUANG Xianghua.
Clinical characteristics and prognosis of IgM associated systemic light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(5): 401-406.
|
[11] |
LIANG Dandan, ZENG Caihong.
Primary hyperparathyroidism associated kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(4): 389-393.
|
[12] |
REN Guisheng, GUO Jinzhou, ZHAO Liang, XU Weiwei, CHEN Wencui, LIU Zhihong, HUANG Xianghua.
Efficacy and safety of daratumumab in treatment of relapsed/refractory systemic light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(3): 205-210.
|
[13] |
HUANG Xianghua, LIU Zhihong.
Anti-CD38 monoclonal antibody-based therapy for systemic light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(3): 252-257.
|
[14] |
GUO Jinzhou, REN Guisheng, LIANG Dandan, HUANG Xianghua.
Daratumumab in a patient with relapsed light chain amyloidosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(3): 294-298.
|
[15] |
LIANG Shaoshan, ZENG Caihong.
Renal transplant recipient from a donor with diabetic nephropathy#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(2): 189-193.
|